Details: :( SR PH CODE 153041 ) CORONARY DRUG ELUTING STENTS WITH (1) STENT ONCOBALT CHROMIUM ALLOY OR PLATINUM CHROMIUM ALLOY. (2) STENT WITH COATING OFPOLYMER CARRIER FOR ACTIVE DRUG ( SIROLIMUS, EVEROLIMUS OR ZOTAROLIMUS SHOWN TOBE EFFECTIVE IN PREVENTING NEO-INTIMAL HYPERPLASIA) (3) STENT DIAMETER SHOULD BEFROM 2.5MM TO 4MM . THE LENGTH OF THE STENT SHOULD BE FROM 12MM TO 38 MM . (4) THESTRUT THICKNESS SHOULD BE 91 MICRON OR LESS. (5) STENT DELIVERY SYSTEM SHOULD BEMONORAIL (SINGLE OPERATOR EXCHANGE OR RAPID EXCHANGE). (6) STENT SHOULD BECOMPATIBLE WITH 5FR GUIDING CATHETER (7) STENT DESIGN SHOULD BE OPEN CELL TYPE. (8)STENT SHOULD BE APPROVED BY DCGI. THE COPY OF DCGI APPROVAL SHOULD BE ENCLOSED INTHE TENDER BID / OFFER. (9) THE LONG TERM EFFICACY AND SAFETY OF THE STENT, THE RATESOF IN-STENT RESTENOSIS (ISR) AND IN-SITU THROMBOSIS (IST) SHOULD BE DOCUMENTED /PUBLISHED IN PEER REVIEWED SCIENTIFIC JOURNALS. (10)THE MANUFACTURER/SUPPLIERSHOULD SUBMIT PROOF OF SUPPLY OF THE STENT TO A MAJOR G
Sector: Railways